Search research articles
Contact Us
Filters
Showing results (261-270 of 400) with videos related to
Page
of 40
Sort By:
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
July 1, 1985
Immunological classification of adult lymphocytic leukemia based on the conventional cell markers and monoclonal antibody-defined cell surface antigens
K Kawashima, E Nagura, M Ogura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I study of recombinant human tumor necrosis factor
K Kimura, T Taguchi, I Urushizaki, et al.
British Journal of Haematology
|
January 29, 2000
Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA
A Takeshita, K Shinjo, K Naito, et al.
The Japanese Journal of Antibiotics
|
December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]
H Mizuno, H Yamao, H Saito, et al.
International Journal of Hematology
|
December 1, 1991
Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults
R Ohno, S Yokomaku, M Okumura, et al.
Cancer
|
June 15, 1993
Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group
R Ohno, T Kobayashi, M Tanimoto, et al.
Cancer
|
August 15, 1995
Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia. The Japan Adult Leukemia Study Group
A Takeshita, H Sakamaki, S Miyawaki, et al.
Journal of the National Cancer Institute
|
March 18, 1992
Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine)
R Ohno, K Yamada, M Hirano, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I study of NKT-01
K Tamura, H Niitani, M Oguro, et al.
The Japanese Journal of Antibiotics
|
December 1, 1984
[Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]
S Shimizu, M Hirano, S Shirakawa, et al.
Page
of 40
Search research articles
Search
Showing results (261-270 of 400) with videos related to
Sort By:
Page
of 40
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
July 1, 1985
Immunological classification of adult lymphocytic leukemia based on the conventional cell markers and monoclonal antibody-defined cell surface antigens
K Kawashima, E Nagura, M Ogura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I study of recombinant human tumor necrosis factor
K Kimura, T Taguchi, I Urushizaki, et al.
British Journal of Haematology
|
January 29, 2000
Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA
A Takeshita, K Shinjo, K Naito, et al.
The Japanese Journal of Antibiotics
|
December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]
H Mizuno, H Yamao, H Saito, et al.
International Journal of Hematology
|
December 1, 1991
Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults
R Ohno, S Yokomaku, M Okumura, et al.
Cancer
|
June 15, 1993
Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group
R Ohno, T Kobayashi, M Tanimoto, et al.
Cancer
|
August 15, 1995
Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia. The Japan Adult Leukemia Study Group
A Takeshita, H Sakamaki, S Miyawaki, et al.
Journal of the National Cancer Institute
|
March 18, 1992
Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine)
R Ohno, K Yamada, M Hirano, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I study of NKT-01
K Tamura, H Niitani, M Oguro, et al.
The Japanese Journal of Antibiotics
|
December 1, 1984
[Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]
S Shimizu, M Hirano, S Shirakawa, et al.
Page
of 40